Segment Information (Tables)

12 Months Ended

Dec. 31, 2023

Segment Reporting, Measurement Disclosures [Abstract]

Segment Results

Detailed segment data for the years ended December 31 is as follows ($ in millions):

	2023		2022		2021
Sales:
Biotechnology	$	7,172	$	8,758	$	8,570
Life Sciences	7,141		7,036		6,388
Diagnostics	9,577		10,849		9,844
Total	$	23,890	$	26,643	$	24,802
Operating profit:
Biotechnology	$	1,909	$	3,008	$	3,074
Life Sciences	1,209		1,414		1,293
Diagnostics	2,406		3,436		2,313
Other	(322)		(322)		(303)
Total	$	5,202	$	7,536	$	6,377
Depreciation and amortization of intangible assets:
Biotechnology	$	1,026	$	1,002	$	1,059
Life Sciences	558		531		382
Diagnostics	577		590		614
Other	5		9		7
Total	$	2,166	$	2,132	$	2,062

The following table presents additional detailed segment data for the years ended December 31 ($ in millions):

	2023		2022		2021
Identifiable assets:
Biotechnology	$	37,421	$	37,536	$	38,118
Life Sciences	23,730		17,572		19,768
Diagnostics	14,552		14,722		15,054
Other	8,785		9,739		5,407
Discontinued operations	—		4,781		4,837
Total	$	84,488	$	84,350	$	83,184
Capital expenditures, gross:
Biotechnology	$	417	$	405	$	385
Life Sciences	320		325		210
Diagnostics	546		382		644
Other	100		6		1
Total	$	1,383	$	1,118	$	1,240

Schedule of Operations in Geographical Areas

Operations in Geographical Areas:

	Year Ended December 31
($ in millions)	2023		2022		2021
Sales:
United States	$	9,579	$	11,289	$	9,411
China	3,143		3,611		3,565
All other (each country individually less than 5% of total sales)	11,168		11,743		11,826
Total	$	23,890	$	26,643	$	24,802
Property, plant and equipment, net:
United States	$	2,304	$	1,839	$	1,628
Sweden	425		429		513
United Kingdom	371		239		244
Germany	238		204		200
All other (each country individually less than 5% of total property, plant and equipment, net)	1,215		998		945
Total	$	4,553	$	3,709	$	3,530